Alberta Lung Cancer Screening Program

计划入组 800 人 · 首次发布于 2015 年 5 月 1 日

Alberta Cancer Exercise Pilot Randomized Trial

计划入组 80 人 · 首次发布于 2015 年 1 月 5 日

The Gastric Cancer Foundation: A Gastric Cancer Registry

计划入组 500 人 · 首次发布于 2012 年 1 月 20 日

KP-21

alpha-synuclein inhibiting quinpramine (Synovo/The Michael J. Fox Foundation)

tripropeptin C analogs (Microbial Chemistry Research Foundation)

AHS Cancer Control Alberta

Canada

ICON CANCER FOUNDATION LTD

Australia

Alberta Health Services

Canada

Alberta Cancer Foundation Invests $35-Million to Power Cancer Clinical Trials Across the Province

Pacylex Initiates Phase 1/2 Trial of First-in-Class N-myristoyltransferase Inhibitor Zelenirstat in Relapsed/Refractory AML

High-Dose Niacin Shows Promise in Glioblastoma: Early Trial Reports 28% Improvement in Disease Progression